Impact factor: /ICV:
|
|
- Kimberly Simmons
- 5 years ago
- Views:
Transcription
1 Impact factor: /ICV: Pharma Science Monitor 6(4), Oct-Dec 2015 PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES Journal home page: A CLINICAL STUDY TO ASSESS THE EFFECT OF SAMVARDHANA GHRITA AND YOGA BASTI IN CEREBRAL PALSY Satyawati Rathia 1 *, V. K. Kori 2, Rajagopala S. 2, K. S. Patel 3, Suhas A. Chaudhary 4 1 Ph.D. Scholar, Dept. of Kaumarbhritya, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar , India 2 Assistant Professor, Dept. of Kaumarbhritya, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar , India 3 Professor, Dept. of Kaumarbhritya, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar , India. 4 Lecturer, Dept. of Kaumarbhritya, Shree Gulabkunverba Ayurveda Mahavidyalaya, Gujarat Ayurved University, Jamnagar , India. ABSTRACT Cerebral palsy refers to a group of neurological disorders that appear in infancy or early childhood and permanently affect body movement and muscle coordination.the prevalence of Cerebral Palsy among children is 2 per 1000 live births. In this study 8 patients were completed the treatment. Samvardhana Ghrita orally for 62 days and Udvartana (5days), Abhyanga (5days), Swedana (5days), and Yoga Basti (8 days) given for 86 days. Total 3 courses were done followed by 16 days interval between each course. Personal & Social milestone was improved. Yoga Basti shown improvement in growth (Height, Wei ght and Mid Arm Circumference), development milestone (sitting, standing, fine motor and personal and social).this study shows that improvement was observed in 12.5% patients. Ayurvedic treatment modality was effective in improving the milestones of Cerebral Palsy patients. KEYWORDS: Abhyanga, Cerebral Palsy, Samvardhana Ghrita, Swedana, Udvartana and Yoga Basti. INTRODUCTION Childhood period is considered as the foundation of the better future life and every incidence has influence on the further life. Disability is a major problem those effect the better life of children. While disability is discussed particularly in children, about a quarter of chronic childhood problems are neurological in origin. Cerebral palsy (CP) is caused by damage to or abnormalities inside the developing brain that disrupt the brain s ability to control movement and maintain posture and balance. The term cerebral refers to the brain; palsy refers to the loss or impairment of motor function [1]. In Cerebral palsy some conditions found in classics at different places like Pangulya, Mukatva, Jadatva, Ekanga Roga, Sarvanga Roga, Pakshaghata, Pakshavadha etc, under the group of Vatavyadhi [2]. Contributory factors are like inappropriate Ritu, Kshetra, Ambu
2 Impact factor: /ICV: and Bija [3], Dauhrida Avamanana [4], presence of Garbhopaghatkarbhava [5], incompatible Garbha Vriddhikarabhava [6] and improper following of Garbhini Paricharya [7]. Considering the signs and symptoms of CP, this disease seems very closer to the presentation of Vata Vyadhi. Basti is very helpful in pacifying Vata, further it is glorified that Basti Chikitsa as Ardha Chikitsa of Vata [8]. By these facts, Basti is most important among the Panchakarma in the treatment of CP. There are many types of Bsati. According to number Charak is described three types: Karma, Kala and yoga. This pattern of Basti includes the group of eight Basti, out of which five are Anuvasana and three are Niruha. The schedule is started with Anuvasana on the day one followed by three Niruha and three Anuvasana alternatively. Lastly, one Anuvasana is to be given [9]. Yoga Basti is indicated in Kaphanubandhi Vata Prakopa, Alpa bala and Vata Dosha vatiation [10]. No other Chikitsa has the capacity to pacify and regulate the force of Vata apart from Basti [11]. Same hypothesis was assumed for this clinical trial. Pakwashaya is the seat of Vata Dosha. Basti denotes Karma where the drugs administered through the rectal canal stay for certain period in the body. Then produce the coating of the Sneha in the body and draws out the waste substances from all over the body into the colon and eliminates them out of the body by producing movements in the colon resulting into pleasant (beneficial) effect. According to Charaka, Basti is the Karma in which, the medicine prepared according to classical references is administered through rectal rout and it reaches up to the Nabhi Pradesh, Kati, Parshwa, Kukshi (small intestine) churns the accumulated Dosha and Purisha, spreads the unctuousness (potency of drugs) all over the body and easily comes out along with the Purisha and Dosha (impurity) [12]. In Lehadhyaya chapter of Kashyapa Samhita, reference of such Lehana Yoga named Samvardhana Ghrita is promoting general growth, strength and intellect of children. This Ghrita is mentioned for smooth and rapid growth of child without interference of any disease for healthy child and improving or treating the conditions in Pangu (lame), Muka (dumb), Ashruti (deaf), Jada (idiot) [13]. This reveals the possible efficacy of Samvardhana Ghrita for improving the condition in CP or other similar conditions. MATERIALS AND METHOD Material Diagnosed patient of Cerebral palsy attending O.P.D. & I.P.D. of Kaumarbhritya Department, I.P.G.T. & R.A., Jamnagar were taken for the research work. Samvardhana Ghrita was collected from pharmacy of Gujarat ayurved university Jamnagar. Inclusion criteria:
3 Impact factor: /ICV: Age group - 1 year to 10 years of both sex. 2. Children with severe type of the disability (GMFCS Score upto level 5) were included in study. Exclusion criteria: 1. Children s age < 1 and > 10 years. 2. Children with major congenital disorders. 3. Children with other diseases ex. Juvenile diabetes, tuberculosis, acute infection etc. Method: Study Design: The randomized simple sampling method. LABORATORY INVESTIGATIONS: Blood : Hb, TC, DC, ESR, CRP (If needed) Urine : Routine and microscopic examinations. (If needed) Stool : Routine and microscopic examinations. (If needed) TRIAL OBJECTS: Drug : Samvardhana Ghrita Procedure : Udvartana, Abhyanga, Swedana and Yoga Basti STUDY DESIGN: Patients received Samvardhana Ghita for 62 day orally. Udvartana with Yava and Kulattha for 5 days, Abhyanga with Bala Taila + Nadi Sweda for 5 days and 8 days of Yoga Basti with 16 days of interval, Such 3 courses were repeated. Dose of Samvardhana Ghrita was determined by using reference of Sharngdhara Samhita [14]. (Table no.1) Dose of Basti Dravya is given as per the reference of Charaka Samhita [15] (Table no 2.) Doses for Aasthapana Basti. Anuvasana should be given ¼ of the quantity of Aasthapana Basti. Table 1 Age wise dose of Samvardhana Ghrita Age group Dose (Once / Day) 1 3 yrs. 2.5 gm. 4 7 yrs. 6 gm yrs. 9.5 gm. Sahapana Duration Follow up : Madhu : 62 days : 8 weeks
4 Impact factor: /ICV: Table no 2. Age wise dose of Aasthapana Basti Age in year Prasruta Tola Gms. 1yr 1/ yr yr 1 ½ yr yr 2 ½ yr yr 3 ½ yr yr 4 ½ yr Basti schedule:- Yoga basti was administer as per the schedule that is A N A N A N A A ASSESSMENT COMPONENTS: A= Anuvasana Basti, N= Niruha (Asthapana) Basti Assessment criteria include Centers for diseases Control and prevention(cdc) grading for motor milestones, suitable scoring pattern was prepared for Fine Motor, Language and Personal and Social milestones, Ashworth Scale to assess spasticity, Muscle Power grading, Manual Ability Classification System (MACS) to assess the function of upper limb, Gross Motor Functions Classification System (GMFCS) and Activities of Daily Living score (ADL) was taken as assessment criteria to observe the effect of therapy. Table no 3. ASSESSMENT OF TOTAL EFFECT OF THERAPY: Complete Remission Marked Improvement Moderate Improvement 100% improvement of clinical signs and symptoms. More than 75% to 99% improvements of clinical signs and symptoms. More than 50% to 75% improvement of clinical signs and symptoms. Mild Improvement More than 25% to 50% improvement of clinical signs and symptoms. Improvement More than 10% to 25% improvement of clinical signs and symptoms. Unchanged 0 to 10% improvements of clinical signs and symptoms. Worsened Less than 0% worsened of clinical signs and symptoms. Statistical analysis was done by using paired t and student unpaired t test. Discussion Samvardhana Ghrita Samvardhana Ghrita is described in Lehadhyaya chapter of Kashyapa Samhita. It is mentioned for smooth and rapid growth of child without interference of any disease for healthy
5 Impact factor: /ICV: child and improving or treating the impaired conditions in those who are Pangu (lame), Muka (dumb), Ashruti (deaf) and Jada (idiot) [16]. Table no 4. Ingredients of Samvardhana Ghrita: No Ingredients Latin name Part used Qty 1. Khadira Acasia catechu Willd Heart wood 1/7 2. Prishniparni Pseudarthria viscida Desv Whole plant 1/7 3. Syandana Ougenia dalbergiodes Benth Stem Bark 1/7 4. Bala Sida cordifolia Linn Whole plant 1/7 5. Atibala Abutilon indicum Linn Whole plant 1/7 6. Kebuka Costus speciosus Smith Rhizome 1/7 7. Saindhav Sodium Chloride - 1/7 8. Kshira Milk Ghrita Ghee - ½ 10. Jala Water - 4 Pharmacodynemic action of Ingredients of Samvardhana Ghrita are mentioned in Dravya Guna Vigyaniyam, Charak and Susruta Samhita [17-19]. Table no 5. Pharmacodynemic actions of Ingredients of Samvardhana Ghrita: No. Ingredients Rasa Guna Virya Vipaka Karma 1. Khadira Tikta, Laghu, Ruksha Sheeta Katu Pachana Kashaya 2. Prishniparni Madhura, Tikta Laghu, snigdha Ushna Madhura Balya, Vatahara, 3. Syandana Kashaya Laghu, Ruksha Sheeta Katu Rasayana 4. Bala Madhura Snigdha Sheeta Madhura Balya, Rasayana 5. Atibala Madhura Snigdha Sheeta Madhura Balya, Rasayana 6. Kebuka Tikta Laghu, Ruksha Sheeta Katu Deepana, Pachana, 7. Saindhav Lavana Snigdha, Ushna, Tikshna Anushna Sheeta and Madhura Deepana, Pachana Sheeta 8. Kshira Madhura Mridu, Snigdha Sheeta Madhura Medhya, 9. Ghrita Madhura Snigdha, Mridu, Guru 10. Jala Madhura Laghu, Sukshma,Vishada Observations: Balya Sheeta Madhura Medhya, Balya, Rasayana, Sheeta Madhura Medhya, Balya, Rasayana Total 8 Patients were completed the present study. In the clinical study maximum number of (45%) of the Patients belonged to age group of 4-7years and 82% were males. Majority of them belonged to Hindu religion (82%),middle socio -economic status(73%),education not started
6 Impact factor: /ICV: (91%).In antenatal history of mother Hyperemesis gravidarum(45%),infection(9%)and hypertension(18%),trauma, antepartum hemorrhage, were (5-5%).maximum patients were delivered in hospital(82%), LSCS(27%), Forceps delivery(9%), Preterm(27%),normal Birth Low birth weight(18%),very low birth weight(18%),delayed cried after birth(55%),convulsion, pathological jaundice and fever ( 36%), meconium aspiration(27%), birth asphyxia, cord around neck, septicemia (9%). Hospitalization was required (36%),Resuscitation(55%) according to feeding pattern during neonatal period Breast fed (45%) and Breast + bottle feeding (65%).Spastic CP (82%),Hypotonic (18%), severe type of CP (64%) and moderate type(27%) (25%) and mild type (9%). The signs and symptoms reported included, developmental delay, feeding problem, language impairment( %), vision problem, hearing problem and abnormal movements (9%) and mental retardation (36%),Spasticity, contractures were observed in 82%, 45%, patients respectively. Impaired co-ordination, impaired orientation, and poor head growth (Microcephal y) were found in 82%, 73%, and 45% patients, recurrent respiratory tract infection(18%), Bowel control Not Achieved (45%),Bladder control not achieved (55%), Feeding Difficulties and Excessive salivation (64%), Constipation (18%), Liquid(45%), semisolid(36%) and solid (18%), Proper immunization (100%), joint family(36%) and nuclear family(65%). Positive Family history(95% mothers age between years(9%) and fathers belong to 29-36years(9%), Parental history Abortion (11%),Primiparity(89%),H/o Consanguinity (18%) use of anti epileptic drug (AED)(9%) and Muscle relaxant (18%), physiotherapy was taken by 36% of patients. EFFECT OF THERAPY ON ASSESSMENT CRITERIA Anthropometric measurement Patients treated with Samvardhana Ghrita and Yoga Basti, improvement was found in length (0.12%), weight (1.75%), Chest circumference (0.27) and Mid thigh circumference(0.35) n=8 Percentage % Series 1 0 Length Weight Chest circumference Mid thigh circumference Figure 1. Effect of therapy on Anthropometric measurement
7 Impact factor: /ICV: Development milestone Patients treated with Samvardhana Ghrita and Yoga Basti, improvement was found in neck holding (8.33%), sitting (8.33%), standing (6.66%), Fine motor (7.7%) language (14.48%), personal and social milestones (17.29%) and gross motor classification system (GMFCS) (11.42%) % 18.00% 16.00% 14.00% 12.00% 10.00% 8.00% 6.00% 4.00% 2.00% 0.00% n=8 Series 1 Figure 2. Effect of therapy on Development milestone Probable mode of action: Most of the drugs in Samvardhana Ghrita are having Madhura, Tikta Rasa, Guru Guna, Shita Virya and Madhura Vipaka. As per available reference, drugs like Bala, Atibala, Mandukparni, Ghrita and Kshira is indicated for improving higher brain functions like Medha (Intellectual), Rasayana etc. Indication of Sanvardhana Ghrita in Vaka, Medha, Smruti, Buddhi enhancement, shows its efficacy to target motor, sensory and higher functions. Main causation of Vata is observed and with the use of this Ghrita probable correction takes places at vitiated Vata level and thereby improving in these parameters and clinical signs and symptoms of Cerebral Palsy. Medhya property of Samvardhana Ghrita has also improved Personal & Social milestone in this study.so indication of Samvardhana Ghrita in Vaka, Medha, Smruti, Buddhi enhancement, shows its efficacy to target motor, sensory and higher functions. Udvartana with rukshana effect removes vitiated kapha and ama dosha, clears the orifices of hair follicles and improves lymphatic and blood circulation which is helpful to absorption the drugs to the target site [20]. Abhyanga nourishes the Dhatu and increases their strength. It corrects and prevents disorders caused by affliction of Vata. It helps in the promotion and regulation of the proper functioning of Vata [21]. Swedana relieves stiffness, heaviness and coldness of the body [22].This study shown increased muscle bulk, power and diminished muscle tone through Abhyanga procedure and
8 Impact factor: /ICV: decreased stiffness of body by Swedana Karma. Improvement in muscle bulk, power, tone and developmental milestones with Yoga Basti included, Anuvasana Basti is more beneficial particularly in affliction of Vata [23]. It has Vata Shamana, Balya and Dhatu Poshana and Asthapana Basti (Madhutailika) has Dosha Nirharana properties which removes morbid dosha and to gain strength and complexion [24]. Basti dravya prepared by various drugs like madhu, taila influences the normal bacteria flora of the colon.so vitamin B12 synthesis is increases, which has an important role in the repair and regeneration of nerves [25]. Thus, Udvartana, Abhyanga, Swedana and Yoga Basti act on sharira and manas brumhana. CONCLUSION Samvardhana Ghrita and Yoga Basti is effective in relieving the signs and symptoms and reducing the disability in children with CP.This study, shown result in improving the disease condition. More outcomes is observed in improving the milestones Growth and Motor components, language, personal and social leads to more effectual protocol of combined treatment (Internal medication as well as Panchakarma procedures). ACKNOWLEDGEMENT Author is thankful to his guide and co-guides for their encouragement towards research work. REFERENCES 1. July 2, Agnivesha, Charaka, Drihabala, Charaka Samhita,Sutrasthana, Maharogaadhyaya, 20/11, edited by Dr. Brahmanand Tripathi, Chaukhambha Surbharti Prakashana, Varanasi, 2012; p Devodas Dhanvantari,Sushruta, Susruta Samhita, Sharira Sthana Shukrashonitashuddhisharira adhyaya,2/33,edited by Ambika Dutta Shastri, Chaukhambha Sanskrit Sansthana,Varanasi,2009, p Agnivesha, Charaka, Drihabala, Charaka Samhita,Sharirasthana, Mahtigharbhavkrantiadhyaya, 4/15, Chaukhambha Surbharti Prakashana, Varanasi, 2012, p Agnivesha, Charaka, Drihabala, Charaka Samhita, Sharirasthana, Mahtigharbhavkrantiadhyaya, 4/18, Chaukhambha Surbharti Prakashana, Varanasi, 2012, p. 884.
9 Impact factor: /ICV: Agnivesha, Charaka, Drihabala, Charaka Samhita,Sharirasthana, Mahtigharbhavkrantiadhyaya, 4/27, Chaukhambha Surbharti Prakashana, Varanasi,2012, p Agnivesha, Charaka, Drihabala, Charaka Samhita, Sharirasthana, Jatiyasutriyaadhyaya,8/31,Chaukhambha Surbharti Prakashana, Varanasi,2012, p Agnivesha, Charaka, Drihabala, Charaka Samhita,Siddhisthana, Kalpanasiddhiadhyaya, 1/40-41, Chaukhambha Surbharti Prakashana, Varanasi, 2007, p Agnivesha, Charaka, Drihabala, Charaka Samhita, Siddhisthana, Kalpanasiddhiadhyaya, 1/47-48 Chaukhambha Surbharti Prakashana, Varanasi, 2005, p Kashyapa, ViridhaJivaka,Vatsya, Kashyap Samhita, Khilsthana, Lehadhayya, edited by Satyapala Bhisagacharya, Chaukhambha Sanskrit Sansthana,Varanasi, 2010; p Devodas Dhanvantari,Sushruta, Susruta Samhita,Chikitsasthana, Netrabastipramanavibhagachikitsa adhyaya,35/29-30,edited by Ambika Dutta Shastri, Chaukhambha Sanskrit Sansthana,Varanasi,2009, p Agnivesha, Charaka, Drihabala, Charaka Samhita, Siddhisthana, Kalpanasiddhiadhyaya, 1/40-41, Chaukhambha Surbharti Prakashana, Varanasi,2005, p Kashyapa,ViridhaJivaka,Vatsya,KashyapSamhita,SutraSthana,Lehadhayya,edited by Satyapala Bhisagacharya, Chaukhambha Sanskrit Sansthana,Varanasi, 2010; p Yogaratnakara,with vaidyaprabha hindi commentary, BalarodhikaraAdhyaya 6/39-42edited by Dr. Indradev Tripathi, Chaukhambha Krishnadas Academy,Varanasi, 2011,p Agnivesha, Charaka, Drihabala, Charaka Samhita, Sharirasthana, Khuddikagharbhavkrantiadhyaya, 3/31-32, Chaukhambha Surbharti Prakashana,Varanasi,2005, p Kashyapa, ViridhaJivaka,Vatsya, Kashyap Samhita, Sutrasthana Lehadhayya, edited by Satyapala Bhisagacharya, Chaukhambha Sanskrit Sansthana,Varanasi, 2010; p Acharya Priyavrata Sharma, Dravya Guna Vigyaniyam, Varanasi, Chaukhambha Bharati Academy, Varanasi,2005, p. 159,605,676,734,736, Agnivesha, Charaka, Drihabala, Charaka Samhita, Sutrasthana, Annapanavidhiadhyaya, 27/202, Chaukhambha Surbharti Prakashana, Varanasi, 2012, p Devodas Dhanvantari,Sushruta, Susruta Samhita, chikitsasthana, Netrabastipramanavibhagachikitsa adhyaya,45/26,edited by Ambika Dutta Shastri, Chaukhambha Sanskrit Sansthana,Varanasi,2009, p.220.
10 Impact factor: /ICV: Agnivesha, Charaka, Dridhabala, Chakrapani, Charaka Samhita, Sutra Sthana, 3/18, Yadavjitrikamji, Ayurveda Dipika, Chaukhamba Prakashana, Varanasi 2009,p Vagbhat, Asthanga Hridya, Sutrasthana, Dincharyaadhyaya,2/8,edited by Dr.Brahmanand Tripathi, Chaukhambha Sanskrit Pratishthana, Delhi,2011,p Agnivesha, Charaka, Drihabala, Charaka Samhita, Sutrasthana, Langhanabrumhniyaadhyaya, 22/11, Chaukhambha Surbharti Prakashana,Varanasi,2012, p Agnivesha, Charaka, Drihabala, Charaka Samhita, Siddhisthana,Kalpanasiddhiadhyaya, 1/29, Chaukhambha Surbharti Prakashana,Varanasi, 2005, p Devodas Dhanvantari,Sushruta, Susruta Samhita,chikitsasthana, Netrabastipramanavibhagachikitsa adhyaya,35/18,edited by Ambika Dutta Shastri, Chaukhambha Sanskrit Sansthana,Varanasi,2009, p Dr.vasant c. patil, Principles and practice of Panchkarma, chapter 13 Basti Karma Chaukhambha Publications, Delhi, 2014 p.496. For Correspondence Satyawati Rathia
World Journal of Pharmaceutical and Life Sciences WJPLS
wjpls, 2017, Vol. 3, Issue 1, 290-296 Case Study ISSN 2454-2229 Shruthi et al. WJPLS www.wjpls.org SJIF Impact Factor: 4.223 AYURVEDIC MANAGEMENT OF SHIROMARMA ABHIGHATA (TRAUMATIC BRAIN INJURY) S. Shruthi
More informationAyurlog: National Journal of Research in Ayurved Science. Review on description of Seasons in Charakasamhita
Impact factor: 2016: 5.210; 2015: 5.223 ISSN: 2320-7329 1 Ayurlog: National Journal of Research in Ayurved Science Website: http://www.ayurlog.com Volume: 6 th Issue: 7 th Oct- Dec 2018 Review on description
More informationInternational Journal of Applied Ayurved Research ISSN: AN OUTLOOK OF DETERMINATION OF RASAVAHASROTAS 1 Bhadiyadra Bharat L.
International Journal of Applied Ayurved Research ISSN: 2347-6362 AN OUTLOOK OF DETERMINATION OF RASAVAHASROTAS 1 Bhadiyadra Bharat L. 2 Vyas Hitesh A. 3 Vyas M. K. 1 Ph D Scholar, Basic Principles Department,
More informationTAKRA (BUTTERMILK): AN ELIXER OF EARTH. Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Thanniruhalla, Hassan, Karnataka, India.
REVIEW ARTICLE TAKRA (BUTTERMILK): AN ELIXER OF EARTH JYOTI BJ 1, KAVITA MB 2 1 Postgraduate Scholar, 2 Associate Professor Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Thanniruhalla,
More informationReview Article International Ayurvedic Medical Journal ISSN:
Review Article International Ayurvedic Medical Journal ISSN:2320 5091 A REVIEW ON CONCEPTUAL STUDY OF ANNAVAHA SROTASA Meshram D S 1, Pawar K B 2, Nikumbh M B 3, Kodape D T 4 1 Assistant Professor, 3 Professor
More informationThe Karmukata of Svedana Karma: A Critical Analysis Mishra Gaurav, 1 Kumar Ashvini, 2 BA Lohith, 3 Sharma Swati. 4
The Karmukata of Svedana Karma: A Critical Analysis Mishra Gaurav, 1 Kumar Ashvini, 2 BA Lohith, 3 Sharma Swati. 4 1 Post Graduate Scholar, 2 Professor, 3 Associate Professor and Head, Department of Panchakarma,
More informationBhattacharyya Nirupam et al / Int. J. Res. Ayurveda Pharm. 4(5), Sep Oct Review Article.
Review Article www.ijrap.net CLINICAL APPLICATION OF SHADVIDHOPKRAMA: A CRITICAL REVIEW Bhattacharyya Nirupam 1 *, Pujar Muralidhar P 2, M Ashvini Kumar 3, Chaturvedi Ashutosh 1 1 PG Scholar, Department
More informationImpact factor: /ICV: INTEGRATING AYURVEDIC CONCEPTS OF IMMUNITY AND ITS ENHANCEMENT- A REVIEW Mamta Tiwari* 1, Anurag Pandey 2
Impact factor: 0.3397/ICV: 4.10 94 Pharma Science Monitor 6(1), Jan-Mar 2015 PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES Journal home page: http://www.pharmasm.com INTEGRATING
More informationInternational Journal of Ayurveda and Pharmaceutical Chemistry
International Journal of Ayurveda and Pharmaceutical Chemistry Volume 7 Issue 2 2017 www.ijapc.com Managed by Green m RESEARCH ARTICLE www.ijapc.com e-issn 2350-0204 The Role of Karnadhupan in the Management
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Review Article Physiological and Clinical Significance of Srotas Vd. Khendkar Jayashree Chandrakant 1, Pawar Jatved Janardanrao
More informationSthaulya has been learned. Symptoms of thesee two have been reviewed and compared. The difference be-
Research Article International Ayurvedic Medical Journal ISSN:2320 5091 COMPARATIVE STUDY OF MEDAVRIDDHI & STHAULYAA QUOTED IN BRIHATRAYI FROM THE DESK OF KRIYA SHARIR Ohol Saritaa Vilas 1, Waghulade Hemangini
More informationDiet in Psoriasis - An Ayurvedic Perspective
Review Article Diet in Psoriasis - An Ayurvedic Perspective Journal of Indian System of Medicine 1 2 Sanjeev.S.Tonni, Shamshad Begum 1 2 Asst. Prof.,Dept. of Swasthavritta, Scholar, Dept of Panchakarma,
More informationUNDERSTANDING PRAMEHA THROUGH TRISUTRA SIDDHANTA
Impact factor: 3.958/ICV: 4.10 ISSN: 0976-7908 666 Pharma Science Monitor 8(2), Apr-Jun 2017 PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES Journal home page: http://www.pharmasm.com
More informationWorld Journal of Pharmaceutical and Life Sciences WJPLS
wjpls, 2018, Vol. 4, Issue 10, 52-56 Review Article ISSN 2454-2229 Sanglae et al. WJPLS www.wjpls.org SJIF Impact Factor: 5.088 REVIEW OF PRAMEHA WITH SPECIAL REFERENCE TO AVYAYAM HETU Vd. Anant A. Sangale
More informationInternational Journal of Ayurveda and Pharma Research
International Journal of Ayurveda and Pharma Research ISSN: 2322-0902 (P) ISSN: 2322-0910 (O) Review Article ROLE OF NIDANA PANCHAKA IN VARIOUS AYURVEDIC ASPECTS Mona Bajpai 1 *, Meenakshi Malik 1, K.Venkat
More informationREFERENCE TO EMBRYOLOGY
INTERNATIONAL AYURVEDIC MEDICAL JOURNAL International Ayurvedic Medical Journal, (ISSN: 2320 5091) (August, 2017) 5(8) A REVIEW ON DEVELOPMENT OF THE MOOLASTHANA OF SROTASS WITH REFERENCE TO EMBRYOLOGY
More informationAntimicrobial study of Anandbhairav Ras (Atisar Adhikar) on stock enteropathogenic bacteria w.s.r. to bacterial food poisoning
World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original
More informationA A M J Anveshana Ayurveda Medical Journal
A A M J Anveshana Ayurveda Medical Journal wwwaamjin ISSN: 2395-4159 Review Article Critical Review on the Concept of Harish Kumar 1 Prasad Prabhakharrao Pande 2 Pradnya Deshpande 3 Harpreet Kaur 4 A b
More informationREVIEW OF HRIDROGA WITH SPECIAL REFERENCE TO VEG-VIDHARAN HETU
Review Article International Ayurvedic Medical Journal ISSN:2320 5091 REVIEW OF HRIDROGA WITH SPECIAL REFERENCE TO VEG-VIDHARAN HETU Marathe Amruta Dilip 1, Aher Priyanka Ashok 2, Joshi Mohon Ramachandra
More informationAnatomical considerations on sira in Ayurveda with special reference to Sushruta Samhita
International Journal of Ayurvedic Medicine, 2013, 4(4), 320-327 Anatomical considerations on sira in Ayurveda with special reference to Sushruta Samhita Review Article Kumar BMN 1 *, Awasthi HH 2 1. Asstt.Professor,
More informationCONCEPTUAL STUDY ON ROLE OF LIFESTYLE MODIFICATION IN THE MANAGEMENT OF OBESITY
Review Article International Ayurvedic Medical Journal ISSN:2320 5091 CONCEPTUAL STUDY ON ROLE OF LIFESTYLE MODIFICATION IN THE MANAGEMENT OF OBESITY Kodrani Priya* 1, Patel D. V. 2 * 1 P.G.Scholar, Upgraded
More informationSPREADSHEET MODELS FOR FOCUSING RESEARCH ON HIGH YIELD PREVENTION AND CONTROL STRATEGIES
Department of Epidemiology Course EPI 415 School of Public Health University of California, Los Angeles Session 18 SPREADSHEET MODELS FOR FOCUSING RESEARCH ON HIGH YIELD PREVENTION AND CONTROL STRATEGIES
More informationA B S T R A C T INTRODUCTION. ISSN: REVIEW ARTICLE Sep-Oct 2016
Concept of Manasa Prakruti as described in Charaka Samhita Sachin S. Bagali, Umapati C. Baragi 1 Assistant Professor, 1 Reader, Department of Basic Principles, BLDEA S, AVS Ayurveda Mahavidyalaya, Vijayapur,
More information2. Assistant Professor, Dept. Of Kriyasharir, SGR Ayurved College, Solapur Maharashtra,
Review Article International Ayurvedic Medical Journal ISSN:2320 5091 SUSHRUTA SAMHITA COMPLETE TREATISE OF AYURVEDA- A REVIEW ARTICLE Madgundi Anand K 1 Ade Jaykumar S 2 Bhabad Pradeep R 3 Jain Atul S
More informationSelecting Foundation and Replacement Goats
Selecting Foundation and Replacement Goats G. L. M. Chappell Terry K. Hutchens Department of Animal Sciences College of Agriculture University of Kentucky The selection of goats to begin a flock or add
More informationThe concept of Antimicrobial Activity in Ayurveda and the effect of some indigenous drugs on Gram-Negative Bacteria
International Journal Of Ayurvedic And Herbal Medicine 1:2 (2011)27:39 Journal Homepage http://interscience.org.uk/index.php/ijahm ISSN-2249-5746 The concept of Antimicrobial Activity in Ayurveda and the
More informationPharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection Quenzer R W, Pettit K G, Arnold R J, Kaniecki D J
Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection Quenzer R W, Pettit K G, Arnold R J, Kaniecki D J Record Status This is a critical abstract of an economic evaluation
More informationCHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY
CHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Antibiotics One of the most commonly used group of drugs In USA 23
More informationLyme Disease. Lyme disease is a bacterial infection spread by tick bites from infected blacklegged
Lyme Disease Lyme disease is a bacterial infection spread by tick bites from infected blacklegged ticks. The bacteria that causes the disease is Borrelia burgdorferi, a spirochete. The earliest symptoms
More informationDon t let arthritis slow down your dog!
Don t let arthritis slow down your dog! abcd DOG CAT ACUTE CHRONIC PERIOPERATIVE INJECTABLE ORAL SUSPENSION CHEWABLE Keeping your dog in the prime of life Is your dog at risk of developing arthritis? As
More informationWeekly Schedule of Neuroscience (2017/2018) Week 1
Week 1 28/1/2018 29/1/2018 30/1/2018 31/1/2018 1/2/2018 8:00 9:00 Health politics & 9:00 10:00 Introductory lecture Gross morphology of the brain Gross morphology of spinal cord Health politics & Blood
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Amikacin 250 mg/ml Injection
PACKAGE LEAFLET: INFORMATION FOR THE USER Amikacin 250 mg/ml Injection Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again. If you
More informationAjantha et al Asian Journal of Pharmaceutical Research and Development. 2018; 6(4): 86-91
Asian Journal of Pharmaceutical Research and Development (An International Peer-Reviewed Journal of Pharmaceutical Research and Development) 2013-18, publisher and licensee AJPRD, This is an Open Access
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT COXEVAC suspension for injection for cattle and goats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains:
More informationPATIENT INFORMATION LEAFLET DYNA CEFPODOXIME 100 mg / DYNA CEFPODOXIME SUSPENSION:
SCHEDULING STATUS S4 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: DYNA CEFPODOXIME 100 mg (film coated tablet) DYNA CEFPODOXIME SUSPENSION (powder for oral suspension) Please read this leaflet carefully
More informationDelayed Prescribing for Minor Infections Resource Pack for Prescribers
Delayed Prescribing for Minor Infections Resource Pack for Prescribers Background: Antibiotic resistance is an alarming threat to modern healthcare, and infectious illness remains a major global threat
More informationQuestions and answers on serious non-fatal adverse events and reporting rules
12 April 2017 EMA/CVMP/PhVWP/303762/2012-Rev.1 Committee for Medicinal Products for Veterinary Use Questions and answers on serious non-fatal adverse events and reporting rules This questions and answers
More informationUnderstanding your pet s LIVER CONDITION
Understanding your pet s LIVER CONDITION Why is the liver so important? What causes liver disease in dogs and cats? The liver is one of the largest organs in your pet s body, and it s vital for their good
More informationAuthor - Dr. Josie Traub-Dargatz
Author - Dr. Josie Traub-Dargatz Dr. Josie Traub-Dargatz is a professor of equine medicine at Colorado State University (CSU) College of Veterinary Medicine and Biomedical Sciences. She began her veterinary
More informationNew Zealand Consumer Medicine Information
New Zealand Consumer Medicine Information FLUCLOXACILLIN Flucloxacillin (as the sodium salt) 250 mg and 500 mg capsules Flucloxacillin (as the sodium salt) 125 mg/5 ml and 250 mg/5 ml powder for oral solution
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur...
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT WONDERCEF powder and solvent for solution for injection for horses not intended for the production of foods for human consumption.
More informationFull Name: Spouse/Partners Name: Home Address: Address:
CLIENT INFORMATION Full Name: Spouse/Partners Name: Home Address: Telephone Numbers (checkmark your primary contact number): Home: Cell: Work: Email Address: Please note that we send monthly e-newsletters
More informationFeline Wellness Report
Demo/Sample Clinic Feline Wellness Report 59 YOUR CAT'S AGE, IN HUMAN YEARS: Environment, genetics, nutrition and size are factors in determining a cat's age. Although this calculation is not exact, it
More informationInt J Ayu Pharm Chem. Preventive Health Measures in Ayurveda. Guru Sharan Pal REVIEW ARTICLE. Abstract
Int J Ayu Pharm Chem REVIEW ARTICLE www.ijapc.com e-issn 2350-0204 Preventive Health Measures in Ayurveda * Nitishwar Ayurveda College Muzaffarpur, Bihar, India Abstract Ayurveda emphasizes on preventive
More informationThe College of Veterinarians of Ontario. Guidelines. for the Compounding of Veterinary Drugs
The College of Veterinarians of Ontario Guidelines for the Compounding of Veterinary Drugs GUIDELINES Compounding of Veterinary Drugs Approved by Council: September 26, 2007 Publication Date: Website September
More informationCLINICAL PROTOCOL FOR COMMUNITY ACQUIRED PNEUMONIA. SCOPE: Western Australia. CORB score equal or above 1. All criteria must be met:
CLINICAL PROTOCOL F COMMUNITY ACQUIRED PNEUMONIA SCOPE: Western Australia All criteria must be met: Inclusion Criteria Exclusion Criteria CB score equal or above 1. Mild/moderate pneumonia confirmed by
More informationEarly Onset Neonatal Sepsis (EONS) A Gregory ST6 registrar at RHH
Early Onset Neonatal Sepsis (EONS) A Gregory ST6 registrar at RHH Background Early onset neonatal sepsis (EONS) is a significant cause of mortality and morbidity in newborn babies. Prompt antibiotic treatment
More informationCritical Appraisal Topic. Antibiotic Duration in Acute Otitis Media in Children. Carissa Schatz, BSN, RN, FNP-s. University of Mary
Running head: ANTIBIOTIC DURATION IN AOM 1 Critical Appraisal Topic Antibiotic Duration in Acute Otitis Media in Children Carissa Schatz, BSN, RN, FNP-s University of Mary 2 Evidence-Based Practice: Critical
More informationSuitability of Antibiotic Treatment for CAP (CAPTIME) The duration of antibiotic treatment in community acquired pneumonia (CAP)
STUDY PROTOCOL Suitability of Antibiotic Treatment for CAP (CAPTIME) Purpose The duration of antibiotic treatment in community acquired pneumonia (CAP) lasts about 9 10 days, and is determined empirically.
More informationDr. P. P. Doke. M.D., D.N.B., Ph.D., FIPHA. Professor, Department of Community Medicine, Bharati Vidyapeeth Medical College, Pune
Dr. P. P. Doke M.D., D.N.B., Ph.D., FIPHA Professor, Department of Community Medicine, Bharati Vidyapeeth Medical College, Pune 1 Anti microbial resistance is now a global geometrically increasing threat
More informationOral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.
1. NAME OF THE MEDICINAL PRODUCT Nystatin Orifarm, 100 000 IU/ml oral suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains 100 000 IU nystatin. Excipients with known effect: - Methyl parahydroxybenzoate
More informationMINISTRY OF HEALTH, MALAYSIA
LAMPIRAN C Ref. No : Photo 4 x 6 ( Part I : Personal information ) 1. FULL NAME ( FIRST NAME) : ( FATHER'S NAME) : 2. MALE/FEMALE : 3. AGE : 7. NAME OF EMPLOYER / RECRUITING AGENCY : 8. ADDRESS OF EMPLOYER
More informationSynopsis. Takeda Pharmaceutical Company Limited Name of the finished product UNISIA Combination Tablets LD, UNISIA Combination Tablets
Synopsis Name of the sponsor Takeda Pharmaceutical Company Limited Name of the finished product UNISIA Combination Tablets LD, UNISIA Combination Tablets Name of active ingredient Title of the study Study
More informationAyurvedic Aspect of Alark (Rabies) A Peer Review
International Research Journal of Interdisciplinary & Multidisciplinary Studies (IRJIMS) A Peer-Reviewed Monthly Research Journal ISSN: 2394-7969 (Online), ISSN: 2394-7950 (Print) Volume-I, Issue-VIII,
More informationThe rights of patients as consumers: An ancient view
Review Article The rights of patients as consumers: An ancient view Nishant Bhimraj Barapatre, Vishnu Prabhakar Joglekar 1 Department of Agadtantra, Mahila Utkarsh Pratishthan s Ayurved College, Washim,
More informationCOMMITTEE FOR VETERINARY MEDICINAL PRODUCTS
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Information Technology EMEA/MRL/728/00-FINAL April 2000 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS STREPTOMYCIN AND
More informationWeekly Schedule of Neuroscience (2018/2019) Week 1
Week 1 27/1/2019 28/1/2019 29/1/2019 30/1/2019 31/1/2019 9:00 10:00 Introductory lecture Gross morphology of the brain Gross morphology of spinal cord Health politics & Blood supply of the CNS Language
More informationIACUC Policy on Humane Endpoints in Animal Use Proposals
IACUC Policy on Humane Endpoints in Animal Use Proposals Definitions: moribund \MOR-uh-bund\, adjective: In a dying state; dying; at the point of death. morbid\ MOR-bid\, adjective: pertaining to, affected
More informationPROFESSIONAL PRACTICE STANDARD
PROFESSIONAL PRACTICE STANDARD Dispensing Drugs TBD Introduction Under the Veterinarians Act and Regulations, veterinarians licensed by the College of Veterinarians of Ontario are authorized to engage
More informationVETERINARY SCIENCE CURRICULUM. Unit 1: Safety and Sanitation
Chariho Regional School District - Science Curriculum September, 2016 VETERINARY SCIENCE CURRICULUM Unit 1: Safety and Sanitation Students will gain an understanding of the types of hazards common in veterinary
More informationPreeja Preman et al / Int. J. Res. Ayurveda Pharm. 7(Suppl 3), Jul - Aug Review Article.
Review Article www.ijrap.net COSMETIC SENSE OF AYURVEDA: A REVIEW Preeja Preman 1, Prathibha C. K 2, K. Parameswaran Namboothiri 2, Ananth Ram Sharma 2 * 1 PG Scholar, Amrita School of Ayurveda, Kollam,
More informationHealth Products Regulatory Authority
1 NAME OF THE VETERINARY MEDICINAL PRODUCT Genta 50 mg/ml solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active Substances Gentamicin sulphate equivalent to Gentamicin
More informationAcute Pyelonephritis POAC Guideline
Acute Pyelonephritis POAC Guideline Refer full regional pathway http://aucklandregion.healthpathways.org.nz/33444 EXCLUSION CRITERIA: COMPLICATED PYELONEPHRITIS Discuss with relevant specialist for advice
More informationNEONATAL Point Prevalence Survey. Ward Form
Appendix 2 NEONATAL Point Prevalence Survey Ward Form Please fill in one form for each ward included in PPS Date of survey Person completing form (Auditor code) Hospital Name Department/Ward Neonatal departments
More informationUnshakeable confidence
NEW PRODUCT OF THE YEAR as voted by vets for the 2nd year running** Unshakeable confidence Osurnia is the only otitis externa* treatment that applies like a liquid and stays like a gel. Right where you
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/18
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/18 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Oncept IL-2 lyophilisate and solvent for suspension for injection for cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
More informationEffectiveness of Information Booklet on Knowledge Regarding Dengue Fever And Its Prevention Among Senior Secondary School Students.
IOSR Journal of Nursing and Health Science (IOSR-JNHS) e-issn: 2320 1959.p- ISSN: 2320 1940 Volume 7, Issue 1 Ver. X. (Jan.- Feb.2018), PP 01-05 www.iosrjournals.org Effectiveness of Information Booklet
More informationEPAR type II variation for Metacam
23 June 2011 EMA/674662/2011 International Non-proprietary Name: Meloxicam Procedure No. EMEA/V/C/033/II/084 EU/2/97/004/026, 33-34 Scope: Type II Addition of indication for cats Page 1/6 Table of contents
More informationANNEX III LABELLING AND PACKAGE LEAFLET
ANNEX III LABELLING AND PACKAGE LEAFLET 1 A. LABELLING 2 PARTICULARS TO APPEAR ON THE OUTER PACKAGE AND THE IMMEDIATE PACKAGE Card box and package leaflet for brown glass bottle (Type 1) 1. NAME OF THE
More informationEar drops suspension. A smooth, uniform, white to off-white viscous suspension.
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT OTOMAX EAR DROPS SUSPENSION 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of the veterinary medicinal product contains:
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS Revised: January 2012 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Blackleg Vaccine 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance(s): per ml Five strains
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Fluclon 250 mg Capsules 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 250mg of flucloxacillin as flucloxacillin sodium.
More informationThe Scientific review on clinical and therapeutic aspects of Jalaukavacharan (leech therapy)
World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Available online at: http://www.wjpsonline.org/ Review Article The Scientific review on clinical and therapeutic
More informationSites of IM injections : 1. Ventrogluteal site: site is in the gluteus medius muscle, which lies over the gluteus minimus. 2. Vastus lateralis site:
Sites of IM injections : 1. Ventrogluteal site: site is in the gluteus medius muscle, which lies over the gluteus minimus. 2. Vastus lateralis site: is the thick and well developed in both adults and children.
More informationPrescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):
Prescription Label Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long): Prescribing Veterinarian's Name & Contact Information: Refills: [Content to be provided
More informationECHO: Management of URIs. Charles Krasner, M.D. Sierra NV Veterans Affairs Hospital University of NV, Reno School of Medicine October 16, 2018
ECHO: Management of URIs Charles Krasner, M.D. Sierra NV Veterans Affairs Hospital University of NV, Reno School of Medicine October 16, 2018 Infectious causes of URIs change over time Most ARIs are viral
More informationScientific Discussion post-authorisation update for Rheumocam extension X/007
5 May 2011 EMA/170257/2011 Veterinary Medicines and Product Data Management Scientific Discussion post-authorisation update for Rheumocam extension X/007 Scope of extension: addition of 20 mg/ml solution
More informationCourse Curriculum for Master Degree in Internal Medicine/ Faculty of Veterinary Medicine
Course Curriculum for Master Degree in Internal Medicine/ Faculty of Veterinary Medicine The Master Degree in Internal Medicine/Faculty of Veterinary Medicine is awarded by the Faculty of Graduate Studies
More informationPrevention & Management of Infection post Trans Rectal Ultrasound (TRUS) biopsy
Prevention & Management of Infection post Trans Rectal Ultrasound (TRUS) biopsy Dr. Fidelma Fitzpatrick Consultant Microbiologist, Co-chair, NCCP Prostate Bx Infection Project Board Fidelma.fitzpatrick@hse.ie
More informationSome important information about the fetus and the newborn puppy
Some important information about the fetus and the newborn puppy Dr. Harmon Rogers Veterinary Teaching Hospital Washington State University Here are a few interesting medical details about fetuses and
More informationVETERINARY MEDICINE-VM (VM)
Veterinary Medicine-VM (VM) 1 VETERINARY MEDICINE-VM (VM) Courses VM 603 Veterinary Science: Research and Methods Credit: 1 (1-0-0) Course Description: Conduct of responsible research, contributions of
More informationMy cat has kidney problems and food hypersensitivity what do I do now?
TROVET Renal (Venison), complete, easily digestible, hypoallergenic dietary food for adult cats with an impaired kidney function My cat has kidney problems and food hypersensitivity what do I do now? reliable
More informationMedical Conditions Questionnaire
Medical Conditions Questionnaire (to be completed by the member) Member Full Name.Date of birth. Policy number or scheme name. Please complete the appropriate section(s) only after completing the Member
More informationPackage leaflet: Information for the patient. FLUCLOXACILLIN 250MG/5ML ORAL SOLUTION Flucloxacillin
Package leaflet: Information for the patient FLUCLOXACILLIN 250MG/5ML ORAL SOLUTION Flucloxacillin Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationCAUSES OF DISPOSAL OF MURRAH BUFFALO FROM AN ORGANISED HERD
EAMR, Vol. 1, Issue 1 - July, 2011 CAUSES OF DISPOSAL OF MURRAH BUFFALO FROM AN ORGANISED HERD S. Taraphder 1, S. S. Tomar 2, A. K. Gupta 2, P. K. Panja 3 & P. K. Biswas 4 ABSTRACT : The present study
More informationAntimicrobial Stewardship in Continuing Care. Urinary Tract Infections Clinical Checklist
Antimicrobial Stewardship in Continuing Care Urinary Tract Infections Clinical Checklist December 2014 What is Antimicrobial Stewardship? Using the: right antimicrobial agent for a given diagnosis at the
More informationName Class Date. After you read this section, you should be able to answer these questions:
CHAPTER 14 4 Vertebrates SECTION Introduction to Animals BEFORE YOU READ After you read this section, you should be able to answer these questions: How are vertebrates different from invertebrates? How
More informationDrug Utilization Evalauation of Antibiotics in Dh Uttarakashi
IOSR Journal Of Pharmacywww.iosrphr.org (e)-issn: 2250-3013, (p)-issn: 2319-4219 Volume 7, Issue 9 Version. II (September 2017), PP. 01-05 Drug Utilization Evalauation of Antibiotics in Dh Uttarakashi
More informationThe world s first and only pour-on anti-inflammatory for cattle FAST PAIN RELIEF
The world s first and only pour-on anti-inflammatory for cattle FAST PAIN RELIEF NOTHING IS SIMPLER THAN POUR-ON RELIEF FOR PAIN, FEVER AND ACUTE INFLAMMATION easy to dose easy to apply easy on animals
More informationANNUAL STATISTICAL REPORT FOR ANIMALS USED IN IRELAND UNDER SCIENTIFIC ANIMAL PROTECTION LEGISLATION
ANNUAL STATISTICAL REPORT FOR ANIMALS USED IN IRELAND UNDER SCIENTIFIC ANIMAL PROTECTION LEGISLATION 2013 CONTENTS 1. Introduction 2. Summary 3. Results 3.1 Species and numbers of naive animals used in
More informationA review of Filariasis
International Journal of Current Research in Medical Sciences ISSN: 2454-5716 P-ISJN: A4372-3064, E -ISJN: A4372-3061 www.ijcrims.com Review Article Volume 5, Issue 2-2019 DOI: http://dx.doi.org/10.22192/ijcrms.2019.05.02.005
More informationOffice of Residence Life Service Animal Procedure
Office of Residence Life Service Animal Procedure Content: I. Procedure Statement 1 II. Definitions 1 III. Requesting a Service Animal 2 IV. Animal Health & Well-being 3 V. Conflicting Health Conditions
More informationHOUSE OF REPRESENTATIVES COMMITTEE ON CRIME PREVENTION, CORRECTIONS & SAFETY FINAL ANALYSIS
BILL #: CS/HB 1819 HOUSE OF REPRESENTATIVES COMMITTEE ON CRIME PREVENTION, CORRECTIONS & SAFETY FINAL ANALYSIS **AS PASSED BY THE LEGISLATURE** CHAPTER #: 2002-176, Laws of Florida RELATING TO: SPONSOR(S):
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Excipients: Contains 4% w/w cetyl alcohol and 7% w/w propylene glycol.
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT FLAMAZINE Cream 1 % w/w 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Contains Silver sulfadiazine 1 % w/w Excipients: Contains 4% w/w
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Covexin 10 Suspension for injection for sheep and cattle 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances Potency
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS page 1 of 7 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Panacur PetPaste 187.5 mg/g oral paste for dogs and cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 g oral
More informationIntra-Abdominal Infections. Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018
Intra-Abdominal Infections Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018 Select guidelines Mazuski JE, et al. The Surgical Infection
More informationB. PACKAGE LEAFLET 1
B. PACKAGE LEAFLET 1 PACKAGE LEAFLET FOR: Cadorex 300 mg/ml solution for injection for cattle, sheep and pigs 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION
More informationAntibiotic stewardship in long term care
Antibiotic stewardship in long term care Shira Doron, MD Associate Professor of Medicine Division of Geographic Medicine and Infectious Diseases Tufts Medical Center Boston, MA Consultant to Massachusetts
More informationIntroduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018
Introduction to Chemotherapeutic Agents Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Antimicrobial Agents Substances that kill bacteria without harming the host.
More information